Stocks in play: Aurora Cannabis Inc
Said its Aurora Europe GmbH subsidiary and Ethypharm have once again been selected by the French General Directorate of Health as exclusive suppliers of dried medical cannabis flower until the end of the French trial period. The trial has recently been extended until March 2024. Aurora Cannabis Inc shares T.ACB are trading up $0.01 at $0.74.
Provided Content: Content provided by Baystreet. The Globe and Mail was not involved, and material was not reviewed prior to publication.